Prescriber's Corner

New Agents in the Treatment of Multiple Myeloma

Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, Ali McBride,(2) PharmD, MS, BCPS, BCOP, Hollie Devine,(3) MSN, ANP-BC, Charise Gleason,(4) MSN, NP-BC, AOCNP®, and Sandra Kurtin,(5) RN, MSN, AOCN®, ANP-C, on behalf of the International Myeloma Foundation Nurse Leadership Board

1Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; 2The University of Arizona Cancer Center, Tuscon, Arizona; 3The Ohio State University Medical Center, Columbus, Ohio; 4Emory University, Atlanta, Georgia

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, Cleveland Clinic Taussig Cancer Institute, Multiple Myeloma Program, 9500 Euclid Avenue, Cleveland, OH 44195.
E-mail: faimanb@ccf.org

Authors' disclosures of potential conflicts of interest are found at the end of this article


J Adv Pract Oncol 2016;7:45–52 | doi: 10.6004/jadpro.2016.7.2.13 | © 2016 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me